(Low Wangs views do not represent those of the FDA or the FDA Endocrinologic and Metabolic Drugs Advisory Committee
Even if it is the actual drug, the doses can be too high
For some patients, weight regain despite intensive lifestyle efforts may warrant consideration of resuming tirzepatide or transitioning to alternative anti-obesity medications, provided they meet FDA-indicated criteria (BMI 30 kg/m or 27 kg/m with weight-related comorbidity)
Dont let sleep apnea control another night of your life
In line with histological observations, EtOH feeding caused a 50% increase in total hepatic TG content in WT mice, but had no effect on the hepatic TG content in KO mice (Table 1)
It all happened on March 21, a day after Danish pharma major Novo Nordisks patent protection for its blockbuster diabetes and weight-loss drug, Semaglutide, expired in India